From Concept to Commercialization
“The highest quality, most responsive, and most adaptable service at any point on the path from concept to commercialization.”
Over the past decade, Benchmark Biolabs has served as the link between the biological discovery and the commercial product. Our experienced staff has provided its clients with a full range of scalable services; focused on the validation, development, licensure, and commercialization of their unique technologies.
Localized Expertise with a Global Perspective
Benchmark is uniquely positioned to bring technology platforms to market around the world. Our customized assistance to clients gives them the advantage they need to reach their market goals. Whether world renowned or the newest member of the biotech community, Benchmark is your solution.
- Leading edge research and support, including:
- traditional vaccines
- DNA vaccines and gene delivery
- unique adjuvants and delivery systems
- current influenza antigens (Novel H1N1, H5N1, …)
- more…
- Support for unique platforms:
- adenovirus
- insect cell
- plant cell
- more…
- Regulatory assistance for licensing and product approval.
- product licensing plans
- QA consulting
- more…
Whether it be cutting edge influenza research, or pioneering plant-derived vaccine development with the world’s first licensed product and facility, Benchmark Biolabs leads the way.